Skip to main content
. 2017 Jul 28;8(37):60875–60891. doi: 10.18632/oncotarget.19650

Table 1. Transcripts expressions of matrix metalloproteinases (MMPs) between Kawasaki disease patients and control subjects.

Symbol RefSeq Fold-Change p value Fold-Change p value Fold-Change p value
(KD1 vs. HC) (KD1 vs. HC) (KD1 vs. FC) (KD1 vs. FC) (KD3 vs. KD1) (KD3 vs. KD1)
MMP1 NM_001145938 1.067 0.267 -1.046 0.425 -1.053 0.366
MMP2 NM_001127891 -1.004 0.970 -1.005 0.960 1.092 0.363
MMP3 NM_002422 1.009 0.865 -1.085 0.163 1.014 0.803
MMP7 NM_002423 1.011 0.876 -1.038 0.582 -1.001 0.990
MMP8 NM_002424 7.143 0.001* 2.176 0.083 -7.587 0.001*
MMP9 NM_004994 4.062 0.000* 1.771 0.037* -4.481 0.000*
MMP10 NM_002425 -1.008 0.888 -1.104 0.093 1.020 0.709
MMP11 NM_005940 -1.024 0.825 -1.042 0.709 1.097 0.407
MMP12 NM_002426 1.050 0.389 -1.046 0.427 -1.013 0.814
MMP13 NM_002427 1.008 0.859 -1.100 0.060 1.029 0.531
MMP14 NM_004995 1.072 0.449 -1.059 0.531 1.029 0.756
MMP15 NM_002428 -1.023 0.817 -1.056 0.588 1.064 0.537
MMP16 NM_005941 1.007 0.928 -1.115 0.171 1.049 0.528
MMP17 NM_016155 -1.024 0.797 -1.086 0.388 1.035 0.717
MMP19 NM_002429 1.055 0.580 -1.017 0.864 -1.001 0.988
MMP20 NM_004771 -1.014 0.789 -1.093 0.111 1.026 0.620
MMP21 NM_147191 -1.036 0.546 -1.034 0.567 1.059 0.336
MMP23B NM_006983 -1.060 0.580 -1.070 0.527 1.084 0.449
MMP24 NM_006690 -1.014 0.904 -1.027 0.822 1.052 0.669
MMP25 NM_022468 1.859 0.013* 1.473 0.082 -1.915 0.010*
MMP26 NM_021801 -1.030 0.619 -1.093 0.157 1.069 0.272
MMP27 NM_022122 1.000 0.999 -1.047 0.438 1.055 0.369
MMP28 NM_001032278 1.011 0.914 -1.015 0.877 1.029 0.767

KD1: Kawasaki disease before IVIG treatment; KD3: Kawasaki disease > 3 weeks after IVIG treatment; FC: febrile control; HC: healthy control.